Mesa Biotech, Inc.

📍 San Diego, United States🗓 Founded 2009👥 33 employees💰 Last funded 2019
Medical Equipment Manufacturing🌐 mesabiotech.com
Website LinkedIn
Mesa Biotech is a healthcare test and data company that provides actionable information through trusted, PCR-based infectious disease testing—anytime, anywhere.* Our patented Accula™ System consists of a portable, palm-sized dock and assay-specific test cassettes. Wide access to polymerase chain reaction (PCR) based, Just in Time (JIT) testing enables instant mobility, appropriate treatments, and surveillance. Our mission is to democratize healthcare testing to positively impact human health through actionable data. *The Accula System has received FDA Emergency Use Authorization (EUA) for SARS-CoV-2 (the virus responsible for COVID-19) in vitro diagnostic testing. It is available now for use in patient care settings. The Accula Flu A/Flu B and the Accula RSV tests have obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA).
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Mesa Biotech, Inc.?
Mesa Biotech, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Mesa Biotech, Inc. last raise funding?
The most recent investment in Mesa Biotech, Inc. recorded on gritt.io was in 2019.
When was Mesa Biotech, Inc. founded?
Mesa Biotech, Inc. was founded in 2009.
What industry is Mesa Biotech, Inc. in?
Mesa Biotech, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Mesa Biotech, Inc. based?
Mesa Biotech, Inc. is headquartered in San Diego, United States.